back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-05-29 Tx date 2018-05-24 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$4,791 vol $7.83 each |
$20,117 | |
| Filed 2017-11-14 Tx date 2017-11-09 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$7,390 vol $12.18 each |
$15,326 | |
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
||
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$7,936 vol $11.34 each |
$7,936 | |
| Filed 2016-11-15 Tx date 2011-06-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
||
| Filed 2016-11-14 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
16,567 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$39,993
+2,069 vol $19.33 each |
8,631 | |
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
4,796 | |
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
6,222 | |
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
||
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
||
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
||
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
||
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
||
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$10,003
+340 vol $29.42 each |
6,562 | |
| Filed 2015-08-25 Tx date 2011-06-27 |
$TR
Stem Cell Therapeutics Corp. |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-25 Tx date 2011-06-27 |
$TR
Stem Cell Therapeutics Corp. |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Stem Cell Therapeutics Corp. |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Stem Cell Therapeutics Corp. |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2011-06-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
143,885 | |
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Deferred share units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
0 | |
| Filed 2015-06-17 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
6,562 | |
| Filed 2015-06-12 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
6,222 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
0 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+4,500 vol |
6,167 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-135,000 vol |
1,667 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-50,000 vol |
135,000 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+1,667 vol |
136,667 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
4,796 |